Janwillem Naesens's most recent trade in Cyteir Therapeutics Inc was a trade of 14,150 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 22, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cyteir Therapeutics Inc | Janwillem Naesens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 14,150 | 14,150 | - | - | Stock Option (Right to Buy) | |
Cyteir Therapeutics Inc | Janwillem Naesens | Director | 22 Jun 2021 | 10,000,000 | 0 | - | - | Series B Convertible Preferred Stock | ||
Cyteir Therapeutics Inc | Janwillem Naesens | Director | 22 Jun 2021 | 3,259,026 | 3,259,026 | - | - | Common Stock | ||
Cyteir Therapeutics Inc | Janwillem Naesens | Director | 22 Jun 2021 | 1,109,368 | 0 | - | - | Series C Convertible Preferred Stock | ||
Cyteir Therapeutics Inc | Janwillem Naesens | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 22 Jun 2021 | 277,777 | 3,536,803 | - | 18 | 4,999,986 | Common Stock |